SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-219873
Filing Date
2017-06-30
Accepted
2017-06-30 16:02:15
Documents
2
Effectiveness Date
2017-06-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A d358697ddefa14a.htm DEFA14A 37437
2 GRAPHIC g358697page001.jpg GRAPHIC 16032
  Complete submission text file 0001193125-17-219873.txt   60840
Mailing Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98
Business Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98 353 1 215 8100
Nexvet Biopharma plc (Filer) CIK: 0001618561 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-36828 | Film No.: 17942057
SIC: 2834 Pharmaceutical Preparations